What is Generate Biomedicines, Inc. 's pre-tax income?

Generate Biomedicines, Inc. (GENB) reported pre-tax income of -$61.69M in Q1 2026.

What does pre-tax income mean?

Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.

Generate Biomedicines, Inc. GENB Pre-Tax Income

Pre-Tax Income at other companies

MYR GroupMYRG

$64.03M+95.4%

Piper SandlerPIPR

$87.93M+199%

RepligenRGEN

$1.77M-77.7%

SSR MiningSSRM

$309.96M+193%

LKQLKQ

$167M-24.1%

Sensata TechnologiesST

$115.5M+27.5%

Other financials

Income statement

See full

Revenue$7.2M-18.1%

Operating income-$64.1M-33.1%

Net income-$61.4M-47.4%

EPS (diluted)-$1.07+34.0%

Balance sheet

See full

Cash & equivalents$160.6M-27.2%

Total debt$65.6M—

Total equity$514.8M+209%

Total assets$625.7M—

Cash flow

See full

Operating cash flow-$80.4M-51.2%

CapEx$3.8M+403%

Free cash flow-$84.2M-56.1%

Valuation

See full

Market cap$1.86B—

Enterprise value$1.76B—

Returns & leverage

See full

Debt / equity0.1×—

Current ratio9.2×—

Where this comes from

Reported directly by Generate Biomedicines, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.

The official record: Generate Biomedicines, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Generate Biomedicines, Inc. 's pre-tax income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Generate Biomedicines, Inc. 's pre-tax income?: Generate Biomedicines, Inc. (GENB) reported pre-tax income of -$61.69M in Q1 2026.
What does pre-tax income mean?: Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.